NORD Holding has secured financing for the acquisition of HKS health solutions GmbH, aiming to strengthen its position in the European CDMO market for dietary supplements and pharmaceuticals.

Target Company Overview

The target of this acquisition is HKS health solutions GmbH, a prominent contract manufacturer of high-quality dietary supplements and pharmaceuticals. Established in 2021 through the merger of three companies in the dietary supplement sector, HKS has rapidly grown to employ over 170 staff members and boasts an extensive portfolio of more than 3,000 products.

HKS is recognized for its superior manufacturing capacity and expertise, offering both private label and white-label solutions that adhere to the highest standards, including GMP, IFS, and FSSC certifications. This established reputation positions HKS as an essential player in the market, enhancing its appeal to potential investors.

Industry Overview in Germany

The healthcare and dietary supplement industry in Germany is witnessing substantial growth, driven by increasing consumer awareness about health and wellness. As one of the largest pharmaceutical markets